Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News bluebird bio Inc BLUE

Healthcare Biotechnology
bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. Its lead gene therapy programs for sickle cell disease, B-thalassemia, and cerebral adrenoleukodystrophy and is advancing research to apply new... see more

Recent & Breaking News (NDAQ:BLUE)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE

PR Newswire March 27, 2024

BLUE ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by bluebird bio, Inc.

Accesswire March 27, 2024

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of bluebird bio, Inc. (BLUE) on Behalf of Investors

Business Wire March 27, 2024

bluebird bio Being Investigated on Behalf of bluebird bio, Inc. Investors. Contact Levi & Korsinsky For Details.

Accesswire March 27, 2024

The Law Offices of Frank R. Cruz Announces Investigation of bluebird bio, Inc. (BLUE) on Behalf of Investors

Business Wire March 27, 2024

Did bluebird bio, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - BLUE

Accesswire March 27, 2024

BLUE LOSS ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE

Business Wire March 27, 2024

Shareholder Rights Advocates at Levi & Korsinsky Investigate bluebird bio, Inc. (BLUE) Regarding Possible Securities Fraud Violations

Accesswire March 27, 2024

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against bluebird bio, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire March 27, 2024

bluebird bio Reports Certain Financial Statements Should No Longer Be Relied Upon; Expects To Continue To Report Substantial Doubt Regarding Ability To Continue As A Going Concern - Investors With Losses Encouraged To Contact Kehoe Law Firm, P.C. - BLUE

Newsfile March 26, 2024

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against bluebird bio, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile March 26, 2024

bluebird bio, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - BLUE

Accesswire March 26, 2024

bluebird bio Reports Certain Financial Statements Should No Longer Be Relied Upon And Substantial Doubt Regarding Its Ability To Continue As A Going Concern - BLUE Investors Encouraged To Contact Kehoe Law Firm, P.C.

Accesswire March 26, 2024

bluebird bio, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by bluebird bio (BLUE)

Accesswire March 26, 2024

bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance

Business Wire March 26, 2024

bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call

Business Wire March 25, 2024

Lost Money on bluebird bio, Inc.(BLUE)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

Accesswire March 25, 2024

Did bluebird bio, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- BLUE

Accesswire March 22, 2024

bluebird bio, Inc. (BLUE) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Accesswire March 21, 2024

bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital

Business Wire March 18, 2024